https://www.selleckchem.com/pe....ptide/dulaglutide.ht
The skin condition improved in three patients. There was no significant effect of disease severity on the risk of severe COVID-19 (HR = 0.45; 95% CI 0.32-0.65). Conclusions The course of atopic dermatitis during SARS-CoV-2 infection may be different from the severity of its symptoms due to the lack of a significant influence. The immunosuppressive treatment used in patients with severe AD did not significantly affect the course of SARS-CoV-2 infection.In the last decade, the number of full-time registered dietitians (RDs) serving int
Like
Comment
Share
